PIK3CA and breast cancer: Activating mutations in PIK3CA, the gene that encodes the p110α catalytic subunit, have been identified as potent oncogenic mechanisms implicated in the hyperactivation of this pathway (Figure 2); these mutations are especially noteworthy in breast cancer, where up to 27% of patients have mutations in this gene [41].